Search by Drug Name or NDC

    NDC 62135-0696-12 CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 5; 2.5 mg/1; mg/1 Details

    CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 5; 2.5 mg/1; mg/1

    CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE.

    Product Information

    NDC 62135-0696
    Product ID 62135-696_06fce9d8-ee1b-4486-e063-6394a90aeeb4
    Associated GPIs 49109902450110
    GCN Sequence Number 004902
    GCN Sequence Number Description chlordiazepoxide/clidinium Br CAPSULE 5 MG-2.5MG ORAL
    HIC3 J2B
    HIC3 Description ANTICHOLINERGICS,QUATERNARY AMMONIUM
    GCN 74801
    HICL Sequence Number 002037
    HICL Sequence Number Description CHLORDIAZEPOXIDE/CLIDINIUM BROMIDE
    Brand/Generic Generic
    Proprietary Name CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Chlordiazepoxide Hydrochloride and Clidinium Bromide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 5; 2.5
    Active Ingredient Units mg/1; mg/1
    Substance Name CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
    Labeler Name Chartwell RX, LLC
    Pharmaceutical Class Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA213530
    Listing Certified Through 2024-12-31

    Package

    NDC 62135-0696-12 (62135069612)

    NDC Package Code 62135-696-12
    Billing NDC 62135069612
    Package 120 CAPSULE in 1 BOTTLE (62135-696-12)
    Marketing Start Date 2022-06-08
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.45509
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description CHLORDIAZEPOXIDE-CLIDINIUM CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis